IMAX vs PATH · P/E 59, rev $352.2M vs P/E 19, rev $1.61B
Imax Corp (IMAX) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Imax Corp (IMAX) is a entertainment company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported IMAX revenue for 2024-12-31 was $352.2M. Net income was $32.7M. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. IMAX currently screens at market cap $1.45B and trailing P/E 58.5.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
IMAX currently screens at market cap $1.45B and trailing P/E 58.5. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the IMAX and PATH stock pages for the full models.
Not investment advice.